Weekly live Q&A sessions with health experts provide patients with personalized strategies to complement their treatment plans
The Phase 3 VESALIUS-CV study tested the injected drug when added on to standard therapy of statins or other medications that lower levels of LDL-C, which is sometimes called bad cholesterol. The study recruited over 12,000 patients who never had a heart event but who were at high risk of having one
The latest analysis evaluates performance during a three-year period, from January 2022 to December 2024
While vitamins may seem innocent enough, some can increase your risk of heart disease complications
The molecular and structural/functional changes translate to (1) Tubular atrophy, podocyte hypertrophy, glomerulosclerosis, and microvascular rarefaction and (2) glomerular basement membrane thickening, nephrosclerosis, and extracellular matrix accumulation, respectively [84]